What should I know first?

Guanfacine is an agonist at alpha-2A adrenergic receptors. An agonist activates a receptor. This action differs from blocking a messenger’s return through a transporter.

The UK Intuniv prolonged-release information supports this lesson. Its product-specific ADHD licence and safety rules must be checked separately; the US use on its own or alongside a stimulant is not automatically a UK licensing statement.

This is a mechanism lesson, not a complete medicine guide. A diagram cannot choose treatment, predict your response, or tell you how to change a prescription.

How Brain Cells Communicate

Noradrenaline, also called norepinephrine, can act at several adrenergic receptor types. Alpha-2A names one subtype. A receptor response can change internal signalling rather than directly moving a messenger across the membrane.

A messenger acts at a solid membrane receptor; protein coupling inside the cell illustrates a signaling response, rather than passage through an ion pore. Norepinephrine: A messenger can change signaling through its receptor. Alpha-2A receptor: This receptor symbol identifies a function, not a molecular structure. Cell response: The arrow represents a signaling response, not movement through a pore.
  1. Norepinephrine

    A messenger can change signaling through its receptor.

  2. Alpha-2A receptor

    This receptor symbol identifies a function, not a molecular structure.

  3. Cell response

    The arrow represents a signaling response, not movement through a pore.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

A receptor icon is not an anatomical map or a demonstrated explanation of ADHD symptoms.
About this illustration

A messenger acts at a receptor and changes cell signalling. Alpha-2A is one of several adrenergic receptor subtypes.

How the Medication Changes Signalling

Guanfacine activates central alpha-2A receptors. It is not a central nervous system stimulant. Receptor activation affects cell signalling, but it does not mean that all noradrenaline activity simply increases.

The label also describes effects on sympathetic nerve signals, heart rate and blood pressure. These help explain why the mechanism lesson cannot replace the product’s precautions.

A Closer Look at the Molecular Level

Known action: alpha-2A receptor agonism is established in product pharmacology. The icon does not show a receptor’s atomic structure or a measured activation level.

Clinical uncertainty: the mechanism of guanfacine’s benefit in ADHD is not known. A receptor interaction does not diagnose a signalling deficit or predict attention in a person.

Sources and References

  1. Intuniv 1 mg prolonged-release tablets: UK SmPC

    Product information published on the electronic Medicines Compendium (emc); supplied by pharmaceutical companies.

    Scope: United Kingdom.

  2. What Is a Neurotransmitter?

    Scope: International scientific education; not UK regulatory evidence.

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top